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BACKGROUND: Acute sore throat and group A streptococcal (GAS) pharyngitis is common in Australian children with 36% 
and 12% of children less than 12 years experiencing a sore throat and GAS pharyngitis episode per year. Yet management 
of sore throat remains controversial in urban settings where the impact of antibiotics on symptom reduction is questionable 
and the incidence of acute rheumatic fever is low. Australian practitioners, and many North American and European 
practitioners, do not follow any sore throat guideline, preferring management based on clinical grounds alone. 
OBJECTIVE: For the first time a cost-effectiveness analysis of the management of sore throat in Australian children has 
been conducted using accurate epidemiological data generated from recent Australian studies. 
DESIGN/METHODS: A decision model was constructed to evaluate the short term cost-effectiveness of six strategies to 
manage sore throat using diagnosis and treatment of sore throat based on clinical grounds alone as the comparator. The 
other strategies were: 1) Treat none; 2) Treat all; 3) Culture alone; 4) Rapid antigen test with culture confirmation of 
negative tests and 5) Rapid antigen test alone. The analysis was performed from the health sector perspective and the 
model examined the potential outcomes of pharyngitis including the costs and consequences associated with each 
alternative. 
RESULTS: The average cost-effectiveness for each strategy confirmed that the Treat-all strategy and all the strategies 
based on the use of diagnostic tests were more cost-effective than diagnosis on clinical grounds alone. Similarly, the 
incremental cost-effectiveness ratio (ICER) confirmed that the Treat-none strategy was dominated by clinical grounds and 
diagnosis and treatment based on rapid antigen test alone was the most cost-effective strategy. All other strategies were 
more cost-effective than current practice, costing marginally more per patient for a clear health gain. 
CONCLUSIONS: The greater cost-effectiveness achieved by either culture or rapid antigen test would result in lower 
antibiotic use and reduced impact on the development of bacterial resistance than current Australian practice. 
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